An Extraordinary Year for ROI Research
From the very beginning, the ROI has filled a special niche for radiation oncology by supporting research that provides practical solutions to some of the field’s most pressing challenges. When the ROI released the Improving Diversity and Inclusion in Radiation Oncology request for proposals in the fall of 2019, we recognized an urgent need to address disparities in patient care and to develop a more diverse workforce. The four grants awarded in 2020 took on additional importance and significance with the profound events of this year that brought attention to the inequity and injustice present throughout society.
The ROI is proud to support the four teams who are conducting research that aims to improve cancer care for people of color and those who identify as LGBTQ+. These grants allow for innovative collaborations across disciplines that are necessary to solve the complex problems that they seek to address, and the ROI is uniquely positioned to provide such support. We are hopeful that the outcomes from these research projects will make a difference for medically vulnerable populations and are committed to ensuring that future awards foster equity, inclusivity and diversity both in terms of the patients served and the teams conducting the research.
We were thrilled to see the overwhelming response to the ROI’s recent request for proposals (RFP) on Biomarkers for Radiation Oncology. Many talented researchers saw great potential to investigate new ways to use biomarkers to improve outcomes for patients receiving radiotherapy and submitted 72 letters of intent, shattering the ROI’s previous record of 50. This year’s extraordinarily popular RFP resulted from the successful launch of the ROI’s new Corporate Research Forum who recommended biomarkers as one of three timely and important topics to the ROI’s Research Committee who developed the full RFP. The application review process has begun, and the ROI is looking forward to announcing the awards that will support research on biomarkers to enhance patient selection, develop personalized treatment regimens, quantify outcomes and manage toxicity in Spring 2021.
The ROI is your research foundation, and we are grateful for your continued support as we work toward a better future for all patients and providers in the radiation oncology community.